1 Min Read
* Aclaris Therapeutics announces issuance of two U.S. Patents covering JAK inhibitors for treating hair loss disorders Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.